Results 81 to 90 of about 16,329,415 (166)
Paraurethral Endometrioid Carcinoma Arising From Ectopic Endometriosis: A Case Report
ABSTRACT Introduction Malignant transformation of endometriosis is rare and most commonly involves the ovary; transformation from paraurethral endometriosis is exceedingly rare. Case Presentation A 73‐year‐old postmenopausal woman with prior ovarian endometrioma presented with dysuria and voiding difficulty.
Keita Ogasawara +9 more
wiley +1 more source
ABSTRACT Introduction Enfortumab vedotin plus pembrolizumab has emerged as a standard first‐line therapy for advanced urothelial carcinoma (UC). However, pseudoprogression during this combination remains poorly characterized. Case Presentation A 71‐year‐old man with muscle‐invasive bladder cancer and lymph node metastasis received enfortumab vedotin ...
Yosuke Nakanishi +9 more
wiley +1 more source
Timing and outcomes for radical cystectomy in nonmuscle invasive bladder cancer [PDF]
PURPOSE OF REVIEW To provide an overview on the available clinical and pathological factors in high-risk nonmuscle invasive bladder cancer (NMIBC) patients that help to approximate the risk of progression to muscle invasion and identify 'the' patients ...
Thalmann, George N., Zehnder, Pascal
core +1 more source
On the Conservativeness of Robust Variance Estimators in Propensity Score Weighted Cox Models
ABSTRACT In propensity score weighted analysis, robust variance that does not account for weight estimation (hereafter, uncorrected variance) is commonly used. In propensity score weighted Cox models (CoxPSW), the uncorrected variance is known to be conservative when weights for the average treatment effect (ATE) are used, but it remains unclear ...
Hiroya Morita +3 more
wiley +1 more source
Optimizing neoadjuvant therapy for muscle‐invasive bladder cancer patients who are eligible for cisplatin remains difficult, owing particularly to high toxicity and recurrence rates. This meta‐analysis compared dose‐dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVAC) against durvalumab plus gemcitabine‐cisplatin (D‐GC) and GC alone ...
Maurin Helen Mangold +12 more
wiley +1 more source
Introduction Neoadjuvant chemotherapy (NAC) followed by definitive treatment consisting of either radical radiotherapy or radical cystectomy is the recommended treatment for patients with organ-confined muscle-invasive bladder cancer (OC-MIBC).
Bernard Rachet +7 more
doaj +1 more source
Laparoscopic radical cystectomy - initial experience [PDF]
Introduction: Radical cystectomy with extended pelvic lymph node dissection is the standard treatment for muscle-invasive bladder cancer. The aim of this study is to report our initial experience of our series of 22 patients who underwent laparoscopic ...
Nikolov, Viktor; St. Marina University Hospital +4 more
core +7 more sources
Use of MRI in the diagnosis of bladder cancer: a health economic analysis
BJU International, EarlyView.
Niranjan Sathianathen +4 more
wiley +1 more source
The OR black box in urology: A survey on patient acceptance and confidence in AI‐assisted surgery
Abstract Objectives This study aims to assess patient acceptance of intraoperative video recording with Operating Room (OR) black box technology, characterise consent conditions and use‐case preferences, and identify predictors of patient confidence in artificial intelligence (AI)‐assisted surgery in urological patients.
Julian Risch +12 more
wiley +1 more source
ABSTRACT Pelvic lymph node dissection is an essential component of radical cystectomy (RC) for bladder cancer (BC), but the optimal extent of lymphadenectomy remains uncertain. We conducted a systematic review and meta‐analysis to compare oncologic and perioperative outcomes between extended and non‐extended lymphadenectomy during RC for BC.
Maria Fernanda Dias Azevedo +12 more
wiley +1 more source

